Nieuws

Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates
Mike Heffernan appointed as Chairman of the Board Topline data from Phase 2 LOTUS trial of AVTX-009 for the treatment of ...
Akero Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update
Phase 2b SYMMETRY study preliminary results showed statistically significant reversal of compensated cirrhosis (F4) due to ...